IDEAS home Printed from https://ideas.repec.org/a/spr/ijphth/v60y2015i1p23-30.html
   My bibliography  Save this article

Cost-effectiveness analysis of salt reduction policies to reduce coronary heart disease in Syria, 2010–2020

Author

Listed:
  • Meredith Wilcox
  • Helen Mason
  • Fouad Fouad
  • Samer Rastam
  • Radwan Ali
  • Timothy Page
  • Simon Capewell
  • Martin O’Flaherty
  • Wasim Maziak

Abstract

This study demonstrated that all policies were cost-saving or cost effective, with the combination of reformulation plus labeling and a comprehensive policy involving all three approaches being the most promising salt reduction strategies to reduce CHD mortality in Syria. Copyright Swiss School of Public Health 2015

Suggested Citation

  • Meredith Wilcox & Helen Mason & Fouad Fouad & Samer Rastam & Radwan Ali & Timothy Page & Simon Capewell & Martin O’Flaherty & Wasim Maziak, 2015. "Cost-effectiveness analysis of salt reduction policies to reduce coronary heart disease in Syria, 2010–2020," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 60(1), pages 23-30, January.
    • Handle: RePEc:spr:ijphth:v:60:y:2015:i:1:p:23-30
    DOI: 10.1007/s00038-014-0577-3
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s00038-014-0577-3
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s00038-014-0577-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Andrew Briggs & Mark Sculpher & Martin Buxton, 1994. "Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis," Health Economics, John Wiley & Sons, Ltd., vol. 3(2), pages 95-104, March.
    2. Ünal, B. & Critchley, J.A. & Fidan, D. & Capewell, S., 2005. "Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000," American Journal of Public Health, American Public Health Association, vol. 95(1), pages 103-108.
    3. Radwan Al Ali & Samer Rastam & Fouad Fouad & Fawaz Mzayek & Wasim Maziak, 2011. "Modifiable cardiovascular risk factors among adults in Aleppo, Syria," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 56(6), pages 653-662, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Silvia F Hope & Jacqui Webster & Kathy Trieu & Arti Pillay & Merina Ieremia & Colin Bell & Wendy Snowdon & Bruce Neal & Marj Moodie, 2017. "A systematic review of economic evaluations of population-based sodium reduction interventions," PLOS ONE, Public Library of Science, vol. 12(3), pages 1-22, March.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Beard, N.F., 2014. "Feeding the British Public: a Centenary Review of Food and Drink Manufacturing," Centre for Agricultural Strategy - Papers and Reports 337544, University of Reading.
    2. Simon Wieser & Bruno Horisberger & Sara Schmidhauser & Claudia Eisenring & Urs Brügger & Andreas Ruckstuhl & Jürg Dietrich & Anne Mannion & Achim Elfering & Özgür Tamcan & Urs Müller, 2011. "Cost of low back pain in Switzerland in 2005," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(5), pages 455-467, October.
    3. Martin J. Buxton & Michael F. Drummond & Ben A. Van Hout & Richard L. Prince & Trevor A. Sheldon & Thomas Szucs & Muriel Vray, 1997. "Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life," Health Economics, John Wiley & Sons, Ltd., vol. 6(3), pages 217-227, May.
    4. Isaac Corro Ramos & Maureen P. M. H. Rutten-van Mölken & Maiwenn J. Al, 2013. "The Role of Value-of-Information Analysis in a Health Care Research Priority Setting," Medical Decision Making, , vol. 33(4), pages 472-489, May.
    5. Patricia Rarau & Justin Pulford & Hebe Gouda & Suparat Phuanukoonon & Chris Bullen & Robert Scragg & Bang Nguyen Pham & Barbara McPake & Brian Oldenburg, 2019. "Socio-economic status and behavioural and cardiovascular risk factors in Papua New Guinea: A cross-sectional survey," PLOS ONE, Public Library of Science, vol. 14(1), pages 1-18, January.
    6. Andrew Briggs & Paul Fenn, 1998. "Confidence intervals or surfaces? Uncertainty on the cost‐effectiveness plane," Health Economics, John Wiley & Sons, Ltd., vol. 7(8), pages 723-740, December.
    7. Carina Aguilar Martín & Alessandra Queiroga Gonçalves & Carlos López-Pablo & José Fernández-Sáez & Emma Forcadell Drago & Zojaina Hernández Rojas & Josep Maria Pepió Vilaubí & Dolores Rodríguez Cumpli, 2019. "Ten-Year Follow-Up of Clinical Governance Implementation in Primary Care: Improving Screening, Diagnosis and Control of Cardiovascular Risk Factors," IJERPH, MDPI, vol. 16(21), pages 1-11, November.
    8. John Hutton, 2012. "‘Health Economics’ and the evolution of economic evaluation of health technologies," Health Economics, John Wiley & Sons, Ltd., vol. 21(1), pages 13-18, January.
    9. Berger, Loïc & Bleichrodt, Han & Eeckhoudt, Louis, 2013. "Treatment decisions under ambiguity," Journal of Health Economics, Elsevier, vol. 32(3), pages 559-569.
    10. Andrew H. Briggs & Milton C. Weinstein & Elisabeth A. L. Fenwick & Jonathan Karnon & Mark J. Sculpher & A. David Paltiel, 2012. "Model Parameter Estimation and Uncertainty Analysis," Medical Decision Making, , vol. 32(5), pages 722-732, September.
    11. Helen Mason & Azza Shoaibi & Rula Ghandour & Martin O'Flaherty & Simon Capewell & Rana Khatib & Samer Jabr & Belgin Unal & Kaan Sözmen & Chokri Arfa & Wafa Aissi & Habiba Ben Romdhane & Fouad Fouad & , 2014. "A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-10, January.
    12. Bangzhu Zhu & Runzhi Pang & Julien Chevallier & Yi-Ming Wei & Dinh-Tri Vo, 2019. "Including intangible costs into the cost-of-illness approach: a method refinement illustrated based on the PM2.5 economic burden in China," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(4), pages 501-511, June.
    13. Mikyung Kelly Seo & Oddbjørn Straume & Lars A. Akslen & John Cairns, 2020. "HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?," PharmacoEconomics - Open, Springer, vol. 4(3), pages 529-539, September.
    14. Benjarin Santatiwongchai & Varit Chantarastapornchit & Thomas Wilkinson & Kittiphong Thiboonboon & Waranya Rattanavipapong & Damian G Walker & Kalipso Chalkidou & Yot Teerawattananon, 2015. "Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-15, May.
    15. Gianluca Baio & Laura Magazzini & Claudia Oglialoro & Fabio Pammolli & Massimo Riccaboni, 2005. "Medical Devices: Competitiveness and Impact on Public Health Expenditure," Working Papers CERM 05-2005, Competitività, Regole, Mercati (CERM).
    16. James A. Brander, 2010. "Presidential Address: Innovation in retrospect and prospect," Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 43(4), pages 1087-1121, November.
    17. K Cooper & S C Brailsford & R Davies, 2007. "Choice of modelling technique for evaluating health care interventions," Journal of the Operational Research Society, Palgrave Macmillan;The OR Society, vol. 58(2), pages 168-176, February.
    18. Matthew Franklin & James Lomas & Simon Walker & Tracey Young, 2019. "An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 37(5), pages 631-643, May.
    19. Kaan Sözmen & Belgin Unal & Simon Capewell & Julia Critchley & Martin O’Flaherty, 2015. "Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 60(1), pages 13-21, January.
    20. Sebastian Gurtner, 2013. "An analysis of the influence of framework aspects on the study design of health economic modeling evaluations," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(2), pages 221-230, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:ijphth:v:60:y:2015:i:1:p:23-30. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.